Continuous infusion of interleukin-2 in two relapsed high grade non-Hodgkin lymphoma patients: Effectiveness and tolerability
- 31 December 1991
- journal article
- other
- Published by Elsevier in European Journal of Cancer and Clinical Oncology
- Vol. 27 (4), 521-522
- https://doi.org/10.1016/0277-5379(91)90405-3
Abstract
No abstract availableKeywords
This publication has 3 references indexed in Scilit:
- Recombinant interleukin-2 by continuous infusion and adoptive transfer of recombinant interleukin-2-activated cells in patients with advanced cancer.Journal of Clinical Oncology, 1989
- A Progress Report on the Treatment of 157 Patients with Advanced Cancer Using Lymphokine-Activated Killer Cells and Interleukin-2 or High-Dose Interleukin-2 AloneNew England Journal of Medicine, 1987
- Biological Activity of Recombinant Human Interleukin-2 Produced in Escherichia coliScience, 1984